Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients (Q46570422)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 June 2005
edit
Language Label Description Also known as
English
Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients
scientific article published on 27 June 2005

    Statements

    Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit